---
title: 'Autologous haematopoietic stem cell transplantation for multiple sclerosis:
  a position paper and registry outline'
date: '2023-10-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37780055/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231002180858&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Further clinical trials, including registry-based analyses,
  are urgently needed to better define the patient characteristics, efficacy and safety
  profile of AHSCT compared with other high-efficacy therapies and to optimally position
  it as a treatment option in different MS disease ...'
disable_comments: true
---
CONCLUSION: Further clinical trials, including registry-based analyses, are urgently needed to better define the patient characteristics, efficacy and safety profile of AHSCT compared with other high-efficacy therapies and to optimally position it as a treatment option in different MS disease ...